Erratum to: Malignant Peritoneal Mesothelioma Treated by ...

4 downloads 7 Views 234KB Size Report
Jan 4, 2014 - Erratum to: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal. Chemotherapy: Is GLUT1 ...

Ann Surg Oncol (2014) 21:S778–S779 DOI 10.1245/s10434-013-3389-4

ERRATUM

Erratum to: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study J. Hommell-Fontaine, MD1,5, S. Isaac, MD1,7, G. Passot, MD2,5,7, E. Decullier, PhD4,5,6, A. Traverse-Glehen, MD, PhD1,5, E. Cotte, MD, PhD2,5,7, B. You, MD, PhD3,7, F. Mohamed, MD8, F. N. Gilly, MD, PhD2,5,7, O. Glehen, MD, PhD2,5,7, and F. Berger, MD, PhD1,5 Service d’Anatomie Pathologique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Be´nite, France; 2Service de Chirurgie Ge´ne´rale, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Be´nite, France; 3Service d’Oncologie Me´dicale, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Be´nite, France; 4Unite´ de me´thodologie en recherche clinique, Hospices Civils de Lyon, Pole IMER, Lyon, France; 5Universite´ Lyon 1, Lyon, France; 6Equipe d’Accueil Sante´—Individu Socie´te´, Universite´ de Lyon, Lyon, France; 7Equipe d’Accueil EMR3738 Ciblage the´rapeutique en oncologie, Universite´ Lyon 1, Pierre-Be´nite, France; 8National Pseudomyxoma Peritonei Centre, North Hampshire Hospital, Hampshire, UK

1

ERRATUM TO: ANN SURG ONCOL (2013) 20:3892–3898 DOI 10.1245/S10434-013-3077-4 The authors’ affiliations are correct as presented in this erratum. Figure 1 was incorrect in the original article. The correct figure is as follows:

The online version of the original article can be found under doi:10. 1245/s10434-013-3077-4. Ó Society of Surgical Oncology 2014 Published Online: 4 January 2014 O. Glehen, MD, PhD e-mail: [email protected]

Prognostic Factors in Peritoneal Mesothelioma FIG. 1 Overall survival of patients with DMPM according to the expression of GLUT1 in immunohistochemistry. Patients with expression of GLUT1 (C 5 %) had significantly worse overall survival (log-rank, P \ 0.0001)

S779

Suggest Documents